Booth Bruce — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Booth Bruce has filed 7 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $110.38M.

Profile

Booth Bruce

Bruce Booth is a prominent figure in the biopharmaceutical industry, known for his leadership roles in companies focused on innovative treatments for genetic diseases. He has been involved with Sionna Therapeutics and Vigil Neuroscience, contributing to advancements in therapies for cystic fibrosis and neurological conditions.

RoleInsider
Notability50/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale130$111.20$14K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale1.1K$110.67$119K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale1.1K$109.75$121K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale1.5K$108.28$162K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale2.7K$107.76$291K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale2.1K$106.63$227K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale770$105.78$81K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale934$111.20$104K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale7.7K$110.67$855K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale8.0K$109.75$874K
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale10.8K$108.28$1.17M
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale19.4K$107.76$2.09M
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale14.8K$106.63$1.58M
2026-07-02KYMRKymera Therapeutics, Inc.S — Open-market sale5.5K$105.78$587K
2026-06-30KYMRKymera Therapeutics, Inc.S — Open-market sale157$111.20$17K
2026-06-30KYMRKymera Therapeutics, Inc.S — Open-market sale1.2K$110.67$133K
2026-06-30KYMRKymera Therapeutics, Inc.S — Open-market sale1.2K$109.75$136K
2026-06-30KYMRKymera Therapeutics, Inc.S — Open-market sale1.7K$108.28$183K
2026-06-30KYMRKymera Therapeutics, Inc.S — Open-market sale907$111.20$101K
2026-06-30KYMRKymera Therapeutics, Inc.S — Open-market sale7.6K$110.67$841K

Companies — Last 90 Days

Frequently Asked Questions

Who is Booth Bruce?

Bruce Booth is a prominent figure in the biopharmaceutical industry, known for his leadership roles in companies focused on innovative treatments for genetic diseases. He has been involved with Sionna Therapeutics and Vigil Neuroscience, contributing to advancements in therapies for cystic fibrosis and neurological conditions.…

How many SEC Form 4 filings has Booth Bruce submitted recently?

7 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Booth Bruce been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 104 open-market sales ($110.38M) across all tracked filings.

Where can I see all of Booth Bruce's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Booth Bruce profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.